Bridge to Life Announces Oral and Poster Presentations at The 2026 International Congress of the International Liver Transplantation Society (ILTS) in Geneva, Switzerland, May 6-9, 2026

Bridge to Life Announces Oral and Poster Presentations at The 2026 International Congress of the International Liver Transplantation Society (ILTS) in Geneva, Switzerland, May 6-9, 2026 USA - English USA - Français USA - English News provided by Bridge to Life, Ltd. Apr 28, 2026, 06:00 ET Share this article Share to X Share this article Share to X Presentations to highlight hypothermic oxygenated perfusion (HOPE) with VitaSmart™ in liver transplants, including pediatric patients and partial grafts DULUTH, Ga. , April 28, 2026 /PRNewswire/ -- Bridge to Life™ Ltd., a global innovator in organ preservation solutions and perfusion technology, today announced the presentation of 12 accepted abstracts (five oral, including one Plenary Session presentation, and seven poster presentations, including one late-breaker) at the 2026 International Congress of the International Liver Transplantation Society (ILTS). The conference is scheduled to take place in Geneva, Switzerland, from May 6-9, 2026. All times are Central European Saving Time (CEST), UTC+2. Oral Abstract Presentations Abstract Title: "Donor Serum FMN Reflects Mitochondrial Injury and Predicts Outcomes After Liver Transplantation: A Metabolic Donor Signature of Graft Quality" Session Title: Concurrent Oral Session 4: Selection Criteria, Patient Selection, Organ Allocation Date/Time: Thursday, May 7,2026 at 1:45 pm – 3:00 pm Presenter: Fatma Selin Yildirim, Cleveland Clinic Abstract Title: "Prolonged HOPE Preserves Mitochondrial Function and Enables Logistical Flexibility in Liver Transplantation" Session Title : Concurrent Oral Session 5: Basic Science, Translational Research, and Tolerance Induction 1 Date/Time: Thursday, May 7, 2026 at 3:15 pm – 4:30 pm Presenter: Omer Faruk Karakaya, Cleveland Clinic Abstract Title: "Perfusate Microbiology Before and After Hypothermic Oxygenated Perfusion: A Missing Piece in Graft Assessment" Session Title: Concurrent Oral Session 7: Immunosuppression and Infection Date/Time: Friday, May 8, 10:45 am – 12:00 pm Presenter: Marco Pascale, Policlinico Universitario Agostino Gemelli Abstract Title: "A Donor Risk Factor-Inclusive Machine Learning Equation for Predicting Cholangiocarcinoma Recurrence After Liver Transplantation" Session Title: Concurrent Oral Session 13: Comorbidities and Liver Transplantation Outcomes II Date/Time: Friday, May 8, 2:45 pm – 4:00 pm Presenter: Laura Batista De Oliveira, Cleveland Clinic Abstract Title: "Extended Hypothermic Oxygenated Perfusion in Paediatric Partial Liver Grafts: A Bicentric UK Experience" Session Title: Plenary Abstract Session 2 Date/Time: Saturday, May 9, 8:00 am – 9:15 am Presenter: Alba Bueno, Birmingham Children's Hospital Poster Presentations Late-Breaking Abstract : Poster Title: Sequential Normothermic Regional Perfusion and Hypothermic Oxygenated Machine Perfusion in Liver Grafts from Donors After Circulatory Death Can Protect Against Ischemic Cholangiopathy Presenter: Sergio Cortese, Hospital Universitario Gregorio Maranon Poster Title: Three Years of Experience in the Use of HOPE in a Single Center Presenter: Dora Gomez Pasantes, Complejo Hospitalario Universitario A Coruna Poster Title: "Hypothermic Oxygenated Perfusion (HOPE) Expands Donor Acceptance Criteria with Optimal Outcomes: A Multicenter Matched-Cohort Study" Speaker: Luis Secanella, Hospital Universitario de Bellvitge Poster Title: "Recovering the Discarded Livers Using Hope" Speaker: Mireia Caralt, Hospital Universitario Vall d'Hebron Poster Title: "Impact of HOPE on Very Old DCD (>70 years) Livers: Insights from a Belgian Bi-Centeric Experience" Speaker: Maxime Foguenne, Cliniques Universitaires Saint-Luc Poster Title: "Preliminary Single-Center Experience with Hypothermic Machine Perfusion in Liver Transplantation Using Extended-Criteria Donors" Speaker: Oscar Caso, Hospital Universitario Doce de Octubre Poster Title: "Perfusate-Derived Biochemical Markers During Hypothermic Oxygenated Perfusion Predict Early Allograft Dysfunction After Liver Transplantation" Speaker: Marco Pascale, Policlinico Universitario Agostino Gemelli Bridge to Life Symposium Bridge to Life will also be sponsoring a lunch symposium, "The Future of Machine Perfusion: Combining Strategies, Optimizing Care, and Expanding Possibilities," on May 7, 12:45 p.m. – 1:45 p.m. CEST (UTC+2) in the Palexpo Convention Centre 1, Room K. Speakers include: Damiano Patrono, MD, PhD, AOU Citta della Salute e della Scienza, Torino Rebeca Mateos, MD, University Hospitals Birmingham Andrea Schlegel, MD, MBA, Cleveland Clinic Ohio About Bridge to Life™ Ltd Bridge to Life™ Ltd is a market leader in organ preservation solutions, offering premier products such as Belzer UW ® , EasiSlush ® and the VitaSmart™ Hypothermic Oxygenated Perfusion System . With a strong focus on product quality, innovation and accessibility, the company serves and partners with leading Transplant Centers and Organ Procurement Organizations globally. Logo - https://mma.prnewswire.com/media/2085277/5940096/Bridge_to_Life_New_Logo.jpg 21 % more press release views with Request a Demo × Modal title